Published in Neurology on March 28, 2012
Epilepsy, hippocampal sclerosis and febrile seizures linked by common genetic variation around SCN1A. Brain (2013) 1.95
Actual insights into the clinical management of febrile seizures. Eur J Pediatr (2014) 0.86
Expression Profiling after Prolonged Experimental Febrile Seizures in Mice Suggests Structural Remodeling in the Hippocampus. PLoS One (2015) 0.82
SCN1A and Febrile Seizures in Mesial Temporal Epilepsy: An Early Signal to Guide Prognosis and Treatment? Epilepsy Curr (2014) 0.75
Prevalence of non-febrile seizures in children with idiopathic autism spectrum disorder and their unaffected siblings: a retrospective cohort study. BMC Neurol (2016) 0.75
Epilepsy in children with a history of febrile seizures. Korean J Pediatr (2016) 0.75
Findings from the FEBSTAT Study: Can Observations After a Provoked Seizure Occurrence Have Broad Implications for Epileptogenesis? Epilepsy Curr (2013) 0.75
Psychiatric Comorbidity in Children with Epilepsy: A Cross-sectional 5 Years Rural Prevalence Study. J Neurosci Rural Pract (2017) 0.75
Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial. Lancet (2011) 10.73
Increased absenteeism from work after detection and labeling of hypertensive patients. N Engl J Med (1978) 9.29
Randomised clinical trial of strategies for improving medication compliance in primary hypertension. Lancet (1975) 7.22
One drug for epilepsy. Br Med J (1978) 4.87
Improvement of medication compliance in uncontrolled hypertension. Lancet (1976) 4.84
The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. Brain (2000) 4.76
Anomalous origin of the left coronary artery from the pulmonary trunk. Its clinical spectrum, pathology, and pathophysiology, based on a review of 140 cases with seven further cases. Circulation (1968) 4.34
Mortality from epilepsy: results from a prospective population-based study. Lancet (1994) 4.31
Control of DNA synthesis genes in fission yeast by the cell-cycle gene cdc10+. Nature (1992) 4.13
Hippocampal sclerosis in epilepsy and childhood febrile seizures. Lancet (1993) 3.71
Pathway correcting DNA replication errors in Saccharomyces cerevisiae. EMBO J (1993) 3.57
Reduction in polypharmacy for epilepsy. Br Med J (1979) 3.56
Coordination of expression of DNA synthesis genes in budding yeast by a cell-cycle regulated trans factor. Nature (1991) 3.53
Coordinated regulation of gene expression by the cell cycle transcription factor Swi4 and the protein kinase C MAP kinase pathway for yeast cell integrity. EMBO J (1996) 3.45
A multicopy suppressor gene of the Saccharomyces cerevisiae G1 cell cycle mutant gene dbf4 encodes a protein kinase and is identified as CDC5. Mol Cell Biol (1993) 3.33
SWI6 protein is required for transcription of the periodically expressed DNA synthesis genes in budding yeast. Nature (1992) 3.32
Vigabatrin and behaviour disturbances. Lancet (1990) 3.30
Monotherapy or polytherapy for epilepsy? Epilepsia (1981) 3.25
Remission of epilepsy: results from the National General Practice Study of Epilepsy. Lancet (1995) 3.17
Unnecessary polypharmacy for epilepsy. Br Med J (1977) 3.12
Epileptic seizures in a population of 6000. I: Demography, diagnosis and classification, and role of the hospital services. Br Med J (Clin Res Ed) (1983) 2.95
Epilepsy in a population of 6000 re-examined: secular trends in first attendance rates, prevalence, and prognosis. J Neurol Neurosurg Psychiatry (1995) 2.84
Recovery from chronic fatigue syndrome after treatments given in the PACE trial. Psychol Med (2013) 2.82
Drowning in people with epilepsy: how great is the risk? Neurology (2008) 2.80
P40SDB25, a putative CDK inhibitor, has a role in the M/G1 transition in Saccharomyces cerevisiae. Genes Dev (1994) 2.72
National General Practice Study of Epilepsy: recurrence after a first seizure. Lancet (1990) 2.65
Epidemiology of the epilepsies. J Neurol Neurosurg Psychiatry (1996) 2.62
Randomised controlled trial to assess acceptability of phenobarbital for childhood epilepsy in rural India. Lancet (1998) 2.58
DNA polymerase II, the probable homolog of mammalian DNA polymerase epsilon, replicates chromosomal DNA in the yeast Saccharomyces cerevisiae. EMBO J (1992) 2.51
Falls in the elderly related to postural imbalance. Br Med J (1977) 2.47
The yeast DNA polymerase I transcript is regulated in both the mitotic cell cycle and in meiosis and is also induced after DNA damage. Nucleic Acids Res (1987) 2.38
Comprehensive primary health care antiepileptic drug treatment programme in rural and semi-urban Kenya. ICBERG (International Community-based Epilepsy Research Group) Lancet (1991) 2.36
Infection of the uterine cervix with Chlamydia trachomatis. J Infect Dis (1978) 2.36
Cloning DPB3, the gene encoding the third subunit of DNA polymerase II of Saccharomyces cerevisiae. Nucleic Acids Res (1991) 2.34
Early prognosis of epilepsy. Br Med J (Clin Res Ed) (1982) 2.30
Hippocampal volumetric and morphometric studies in frontal and temporal lobe epilepsy. Brain (1992) 2.29
Neurocysticercosis and epilepsy in developing countries. J Neurol Neurosurg Psychiatry (2000) 2.28
Incidence and prevalence studies in epilepsy and their methodological problems: a review. J Neurol Neurosurg Psychiatry (1987) 2.25
Identification of angiotensin II receptor subtypes. Biochem Biophys Res Commun (1989) 2.23
National General Practice Study of Epilepsy: newly diagnosed epileptic seizures in a general population. Lancet (1990) 2.22
Surgical outcome in patients with epilepsy and dual pathology. Brain (1999) 2.19
Prevention of relapse in residual depression by cognitive therapy: a controlled trial. Arch Gen Psychiatry (1999) 2.12
The intensive care treatment of convulsive status epilepticus in the UK. Results of a national survey and recommendations. Anaesthesia (1995) 2.12
Case-control study of SUDEP. Neurology (2005) 2.11
The treatment gap in epilepsy: the current situation and ways forward. Epilepsia (2001) 2.10
Is cardiac resuscitation worthwhile? A decade of experience. N Engl J Med (1972) 2.07
PAX6 haploinsufficiency causes cerebral malformation and olfactory dysfunction in humans. Nat Genet (2001) 2.05
Integrated hospital and community psychiatric services and use of inpatient beds. BMJ (1989) 2.03
Aetiology of urinary symptoms in sexually active women. Genitourin Med (1986) 2.03
The treatment of epilepsy in developing countries: where do we go from here? Bull World Health Organ (2003) 2.00
Periventricular heterotopia: phenotypic heterogeneity and correlation with Filamin A mutations. Brain (2006) 2.00
Epileptic seizures in a population of 6000. II: Treatment and prognosis. Br Med J (Clin Res Ed) (1983) 1.98
The forkhead protein Fkh2 is a component of the yeast cell cycle transcription factor SFF. EMBO J (2000) 1.95
Validation of a screening questionnaire for the detection of epileptic seizures in epidemiological studies. Brain (1992) 1.94
Apnoea and bradycardia during epileptic seizures: relation to sudden death in epilepsy. J Neurol Neurosurg Psychiatry (1996) 1.89
Cranial cruciate ligament rupture. Pathogenesis, diagnosis, and postoperative rehabilitation. Vet Clin North Am Small Anim Pract (1993) 1.89
Results of cardiac resuscitation in 552 patients. Am J Cardiol (1967) 1.88
The temporal aspects of prognosis in epilepsy. J Neurol Neurosurg Psychiatry (1984) 1.85
Expression of the yeast DNA primase gene, PRI1, is regulated within the mitotic cell cycle and in meiosis. Mol Gen Genet (1990) 1.85
Expanded profile of the SHAFT syndrome. J Hand Surg Am (1998) 1.84
Efficacy assessment of phenobarbital in epilepsy: a large community-based intervention trial in rural China. Lancet Neurol (2006) 1.83
Overlapping and distinct roles of the duplicated yeast transcription factors Ace2p and Swi5p. Mol Microbiol (2001) 1.82
Effects of topiramate on cognitive function. J Neurol Neurosurg Psychiatry (2000) 1.81
The psychiatric comorbidity of epilepsy. Acta Neurol Scand (2004) 1.77
Causes of death among people with convulsive epilepsy in rural West China: a prospective study. Neurology (2011) 1.77
Order of function of the budding-yeast mitotic exit-network proteins Tem1, Cdc15, Mob1, Dbf2, and Cdc5. Curr Biol (2001) 1.76
Oral contraceptives, depression, and libido. Br Med J (1971) 1.74
Association of hippocampal sclerosis with cortical dysgenesis in patients with epilepsy. Neurology (1994) 1.74
Sudden unexpected deaths in epilepsy--where are we now? Seizure (1996) 1.73
Why does epilepsy become intractable? Prevention of chronic epilepsy. Lancet (1983) 1.72
Long-term use of lamotrigine and vigabatrin in severe refractory epilepsy: audit of outcome. BMJ (1996) 1.70
The Skn7 response regulator of Saccharomyces cerevisiae interacts with Hsf1 in vivo and is required for the induction of heat shock genes by oxidative stress. Mol Biol Cell (2000) 1.69
Incidence of epilepsy: a systematic review and meta-analysis. Neurology (2011) 1.68
The prevalence and treatment gap in epilepsy in China: an ILAE/IBE/WHO study. Neurology (2003) 1.66
Mortality in patients with epilepsy: a study of patients in long term residential care. J Neurol Neurosurg Psychiatry (1993) 1.64
Methods for normalization of hippocampal volumes measured with MR. AJNR Am J Neuroradiol (1995) 1.64
A post-mortem study of the cholinergic and GABA systems in senile dementia. Brain (1982) 1.62
Involvement of apoptosis in ovarian follicular atresia and postovulatory regression. Endocrinology (1991) 1.61
Nonpeptide angiotensin II receptor antagonists. XI. Pharmacology of EXP3174: an active metabolite of DuP 753, an orally active antihypertensive agent. J Pharmacol Exp Ther (1990) 1.60
A Bub2p-dependent spindle checkpoint pathway regulates the Dbf2p kinase in budding yeast. EMBO J (1999) 1.60